BeStock  
Markets › Compare › ACAD vs VKTX

ACAD vs VKTX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ACAD · ACADIA Pharmaceuticals$17.11 ▼ 2.73%
VKTX · Viking Therapeutics$24.77 ▼ 4.14%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

668298115131Nov 24, '25May 26, '26Nov 20, '26
  • ACAD -28.4%
  • VKTX -28.5%

Head to head

MetricACADVKTX
Price$17.11$24.77
Change today▼ 2.73%▼ 4.14%
Market cap$2.96B$3.16B
Return, 3 months-42.3%-25.5%
Return, year to date-35.9%-29.6%
Return, 1 year-27.4%-27.7%
P/E (TTM)8.1–
P/B2.15.4
P/E percentile vs own 5y55th81st
Dividend yield––
Revenue growth (YoY, latest qtr)+22.8%–
Net profit growth (YoY)-25.4%-101.8%
Gross margin90.5%–
Operating margin10.2%–
Net margin30.1%–
Return on equity31.4%-96.4%
Analyst target vs. price+85.7%+277.6%
Analyst buy share77%94%
RSI (14)3441
30-day volatility87.3%75.0%
Max drawdown, 1 year-46.0%-42.5%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • VKTX is the largest of the group by market value.
  • ACAD has returned the most over the past year.
  • VKTX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top